Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Life Sciences is Scopus-indexed (Q1, CiteScore 10.7), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier Inc..
Checked against the index lists dated .
ISSN 0024-3205Verify ISSN ↗1879-0631Verify ISSN ↗
Publisher: Elsevier Inc.
Cost to publish: About US$3,810 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (all) | 3 / 79 | 96th | Q1 |
| Biochemistry, Genetics and Molecular Biology (all) | 27 / 223 | 88th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1962–present, best quartile Q1, CiteScore 10.7.
Life Sciences is Q1 in Pharmacology, Toxicology and Pharmaceutics (all) (rank 3 of 79) and Q1 in Biochemistry, Genetics and Molecular Biology (all) (rank 27 of 223), by CiteScore 2025.
Life Sciences is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 10.7, which places it in quartile Q1 at the 96th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.487, quartile Q1, with an H-index of 211.
The publisher lists an article processing charge of about US$3,810 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Life Sciences is published by Elsevier Inc. Its print ISSN is 0024-3205 and its online ISSN is 1879-0631.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Life Sciences has an h-index of 289 and a 2-year mean of 6.38 citations per paper (OpenAlex). Its Scopus CiteScore is 10.7, quartile Q1. On 2-year citations it ranks #3 of 77 Scopus journals in Pharmacology, Toxicology and Pharmaceutics (all).
Life Sciences published 656 papers in 2025; its busiest recent year was 2020 with 1,524. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2026), authors are most often from China (52.9%), United States (6.4%) and Brazil (5.7%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 264 retracted papers are recorded (6.9 per 1,000 papers). The Problematic Paper Screener flags 7 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.